We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$11.4B
AUM Growth
+$1.29B
Cap. Flow
+$528M
Cap. Flow %
4.63%
Top 10 Hldgs %
25.25%
Holding
2,093
New
704
Increased
330
Reduced
366
Closed
687

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$75M
2
CVX icon
Chevron
CVX
+$59.9M
3
GEHC icon
GE HealthCare
GEHC
+$57.5M
4
APP icon
Applovin
APP
+$54.7M
5
OKLO
Oklo
OKLO
+$52.8M

Top Sells

Rank Stock Value
1
XEL icon
Xcel Energy
XEL
+$137M
2
META icon
Meta Platforms (Facebook)
META
+$61.8M
3
BDX icon
Becton Dickinson
BDX
+$59.9M
4
CRWV
CoreWeave
CRWV
+$57.1M
5
AAPL icon
Apple
AAPL
+$50.2M

Sector Composition

Rank Sector Weight
1 Healthcare 11.73%
2 Financials 9.81%
3 Utilities 8.63%
4 Technology 7.6%
5 Industrials 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKRO
1426
DELISTED
Akero Therapeutics
AKRO
– –
-103,930
Closed -$4.21M
ALC icon
1427
Alcon
ALC
$35.6B
– –
-289,711
Closed -$27.5M
ALG icon
1428
Alamo Group
ALG
$2B
– –
-3,150
Closed -$561K
ALKT icon
1429
Alkami Technology
ALKT
$2.18B
– –
-129,709
Closed -$3.4M
ALLE icon
1430
Allegion
ALLE
$13.8B
– –
-154,598
Closed -$20.2M
AMAL icon
1431
Amalgamated Financial
AMAL
$1.46B
– –
-14,796
Closed -$425K
AMCR icon
1432
Amcor
AMCR
$22.5B
– –
-39,338
Closed -$1.91M
AMLX icon
1433
Amylyx Pharmaceuticals
AMLX
$4.31B
– –
-59,491
Closed -$211K
AMN icon
1434
AMN Healthcare
AMN
$1.33B
– –
-70,682
Closed -$1.73M
AMPX icon
1435
Amprius Technologies
AMPX
$1.51B
– –
-15,336
Closed -$41K
AMPY icon
1436
Amplify Energy
AMPY
$200M
– –
-16,067
Closed -$60K
AMRC icon
1437
Ameresco
AMRC
$1.13B
– –
-23,425
Closed -$283K
AMT icon
1438
American Tower
AMT
$81.9B
– –
-86,218
Closed -$18.8M
ANF icon
1439
Abercrombie & Fitch
ANF
$4.84B
– –
-85,819
Closed -$6.55M
AON icon
1440
Aon
AON
$75.3B
– –
-26,994
Closed -$10.8M
APA icon
1441
APA Corp
APA
$15.2B
– –
-338,560
Closed -$7.12M
APG icon
1442
APi Group
APG
$17.8B
– –
-255,803
Closed -$6.1M
APEI icon
1443
American Public Education
APEI
$835M
– –
-21,079
Closed -$470K
APLS
1444
DELISTED
Apellis Pharmaceuticals
APLS
– –
-250,414
Closed -$5.48M
APOG icon
1445
Apogee Enterprises
APOG
$868M
– –
-17,795
Closed -$824K
APPF icon
1446
AppFolio
APPF
$7.95B
– –
-21,171
Closed -$4.66M
AQST icon
1447
Aquestive Therapeutics
AQST
$585M
– –
-189,177
Closed -$549K
ARCO icon
1448
Arcos Dorados Holdings
ARCO
$1.68B
– –
-41,665
Closed -$336K
ARKO icon
1449
ARKO Corp
ARKO
$533M
– –
-162,197
Closed -$641K
ARQT icon
1450
Arcutis Biotherapeutics
ARQT
$3.15B
– –
-242,457
Closed -$3.79M
56 57
58
59 60

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2025 Portfolio in Review

As of Q2 2025, Michael Gelband held 2,093 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Michael Gelband deployed $528M of net new capital in Q2 2025, opening 704 new positions and adding to 330 existing holdings. Its largest new stake was Chevron: 424,949 shares worth $60.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Utilities.

On the sell side, the largest reduction was Xcel Energy, an estimated $137M trimmed.

  • Michael Gelband's largest Q2 2025 buy was Chevron: 424,949 shares worth $60.8M.
  • Michael Gelband added most to Paramount Global Class B in Q2 2025, an estimated $75M increase.
  • Michael Gelband's biggest Q2 2025 reduction was Xcel Energy, cutting an estimated $137M.
  • Michael Gelband fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $61.8M.
  • Michael Gelband's ten largest holdings make up 25% of its $11.4B portfolio in Q2 2025.
  • Michael Gelband opened 704 new positions and closed 687 in Q2 2025.
  • Michael Gelband's portfolio value rose 13% quarter-over-quarter to $11.4B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.